KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Humana (HUM) EPS (Weighted Average and Diluted) (2016 - 2025)

Humana (HUM) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$6.59 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) changed N/A to -$6.59 in Q4 2025 year-over-year; TTM through Dec 2025 was $14.93, a N/A change, with the full-year FY2025 number at $9.84, down 1.4% from a year prior.
  • EPS (Weighted Average and Diluted) was -$6.59 for Q4 2025 at Humana, down from $4.51 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $11.84 in Q3 2021 to a low of -$6.59 in Q4 2025.
  • A 4-year average of $5.52 and a median of $6.55 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 95.15% in 2021; the steepest drop was 66.91% in 2021.
  • Humana's EPS (Weighted Average and Diluted) stood at -$0.1 in 2021, then grew by 20.0% to -$0.08 in 2022, then skyrocketed by 8487.5% to $6.71 in 2023, then plummeted by 198.21% to -$6.59 in 2025.
  • Per Business Quant, the three most recent readings for HUM's EPS (Weighted Average and Diluted) are -$6.59 (Q4 2025), $4.51 (Q2 2025), and $10.3 (Q1 2025).